Bioclinica Acquires Saliency to Accelerate Medical Imaging AI

January 6, 2021

Bioclinica, a Princeton, New Jersey-based clinical life science solutions provider, has acquired Silicon Valley-based Saliency to embed the startup's medical imaging AI into Bioclinica’s Imaging Platform. The acquisition is intended to accelerate image quality control and interpretation for pharmaceutical and medical device clients, enabling faster development of digital diagnostics and digital therapeutics.

Buyers
Bioclinica
Targets
Saliency
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.